In addition, PD-L1 and VEGFR2 in GBM, CTLA4 and PDGFRA in SKCM, as well as PD-L1 and FGFR2 in STAD were all highly expressed genes with driver alterations (Supplementary Table 7). This evidence concerns the gene PDGFRA and gastric adenocarcinoma.